D-1210-2018 Class II Terminated
FDA drug recall D-1210-2018 was initiated by Noven Pharmaceuticals, Inc. on Sep 7, 2018 and is designated Class II. Reason for recall: Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches. The recall status is terminated (terminated Sep 9, 2020). Affected quantity: 74908 boxes of 8 patches.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 3, 2018
- Initiation Date
- Sep 7, 2018
- Termination Date
- Sep 9, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 74908 boxes of 8 patches
Product description
Minivelle (estradiol transdermal system) Patches, Delivers 0.075 mg/day, 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6675-8
Reason for recall
Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.
Distribution pattern
Nationwide
Code information
Lots: 82599 Exp. 05/2019; 82660 Exp. 03/2019; 83396 Exp. 09/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1210-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026